Science
Welcome to EyePod Bayer and a summary of the Nordic Retina Meeting, arranged by Bayer Scandinavia on the 4th - 5th of Feb 2021. The first day focused on the treatment regimens, follow-up and how to exit treatment of nAMD, followed the second day about clinical experiences from the Nordic countries and treatment regimens of RVO, and finally a session on Quality of life and resource allocation for patients with visual impairment. Here, we give you a short summary including some segments from the meeting. -Treatment regimens in nAMD with prof Jean-Francois Korobelnik -Imaging in nAMD and RVO with prof Giovanni Staurenghi -Exit treatment in nAMD patients with prof Justus Garweg and Dr Stamatios Aslanis -Introduction to RVO with Dr Elin Gunnlaugsdottir -Health Economy and Quality of Life with prof Hannu Uusitalu Let us know if you liked this summary by sending us an e-mail. If you are from Scandinavia, let us know if you want the recordings. eyepod@bayer.com MA-M_AFL-DK-0061-1